CD40 and its crucial role as a member of the TNFR family

Seminars in Immunology

Volumn 10, Issue 6, 1998, Pages 435-442

  Vogel, Laura A ^b   Noelle, Randolph J ^a  

^a DARTMOUTH MEDICAL SCHOOL   (United States)

^b NONE

Author keywords

CD40; Immune system; Tumor necrosis factor receptor

Indexed keywords

CD40 ANTIGEN; CELL SURFACE PROTEIN; GLYCOPROTEIN GP 39; IMMUNOGLOBULIN M; TUMOR NECROSIS FACTOR RECEPTOR; TUMOR VACCINE;

ARTHRITIS; ATHEROSCLEROSIS; AUTOIMMUNITY; B LYMPHOCYTE; CELLULAR IMMUNITY; DIABETES MELLITUS; GRAFT VERSUS HOST REACTION; HASHIMOTO DISEASE; HUMAN; HUMORAL IMMUNITY; HYPERIMMUNOGLOBULINEMIA; IMMUNE DEFICIENCY; IMMUNE SYSTEM; IMMUNOLOGICAL TOLERANCE; LEISHMANIASIS; LUPUS ERYTHEMATOSUS NEPHRITIS; NONHUMAN; OVARY INFLAMMATION; PROTEIN STRUCTURE; REVIEW; SIGNAL TRANSDUCTION; TISSUE DISTRIBUTION;

EID: 0010049643     PISSN: 10445323     EISSN: None     Source Type: Journal    
DOI: 10.1006/smim.1998.0145     Document Type: Article

References (78)

1. 1. Smith CA, Farrah T, Goodwin RG (1994) The TNF receptor superfamily of cellular and viral proteins: activation, costimulation, and death. Cell 76:959-962
2. 2. Stamenkovic I, Clark EA, Seed B (1989) A B-lymphocyte activation molecule related to the nerve growth factor receptor and induced by cytokines in carcinomas. EMBO J 8:1403-1410
3. 3. Torres RM, Clark EA (1992) Differential increase of an alternatively polyadenylated mRNA species of murine CD40 upon B lymphocyte activation. J Immunol 148:620-626
4. 4. Clark LB, Foy TM, Noelle RJ (1996) CD40 and its ligand. Adv Immunol 63:43-78
5. 5. Van Kooten C, Banchereau J (1996) CD40-CD40 ligand: a multifunctional receptor-ligand pair. Adv Immunol 61:1-77
6. 6. Quiding-Jarbrink M, Lakew M, Nordstrom I, Banchereau J, Butcher E, Holmgren J, Czerkinsky C (1995) Human circulating specific antibody-forming cells after systemic and mucosal immunizations: differential homing commitments and cell surface differentiation markers. Eur J Immunol 25:322-327
7. 7. Ledbetter JA, Shu G, Gallagher M, Clark EA (1987) Augmentation of normal and malignant B cell proliferation by monoclonal antibody to the B cell-specific antigen BP50 (CDW40). J Immunol 138:788-794
8. 8. Stout RD, Suttles J (1996) The many roles of CD40 in cellmediated inflammatory responses. Immunol Today 17:487-492
9. 9. Paulie S, Rosen A, Ehlin-Henriksson B, Braesch-Andersen S, Jakobson E, Koho H and Perlmann P (1989) The human B lymphocyte and carcinoma antigen, CDw40, is a phosphoprotein involved in growth signal transduction. J Immunol 142:590-595
10. 10. Uckun FM, Gajl-Peczalska K, Myers DE, Jaszcz W, Haissig S, Ledbetter JA (1990) Temporal association of CD40 antigen expression with discrete stages of human B-cell ontogeny and the efficacy of anti-CD40 immunotoxins against clonogenic B-lineage acute lymphoblastic leukemia as well as B-lineage non-Hodgkin's lymphoma cells. Blood 76: 2449-2456
11. 11. Hollenbaugh D, Mischel-Petty N, Edwards CP, Simon JC, Denfeld RW, Kiener PA, Aruffo A (1995) Expression of functional CD40 by vascular endothelial cells. J Exp Med 182:33-40
12. 12. Galy AH, Spits H (1992) CD40 is functionally expressed on human thymic epithelial cells. J Immunol 149:775-782
13. 13. Foy TM, Aruffo A, Bajorath J, Buhlmann JE, Noelle RJ (1996) Immune regulation by CD40 and its ligand GP39. Ann Rev Immunol 14:591-617
14. 14. Noelle RJ, Roy M, Shepherd DM, Stamenkovic I, Ledbetter JA, Aruffo A (1992) A 39-kDa protein on activated helper T cells binds CD40 and transduces the signal for cognate activation of B cells. Proc Natl Acad Sci USA 89:6550-6554
15. 15. Armitage RJ, Fanslow WC, Strockbine L, Sato TA, Clifford KN, Macduff BM, Anderson DM, Gimpel SD, Davis-Smith T, Maliszewski CR et al (1992) Molecular and biological characterization of a murine ligand for CD40. Nature 357:80-82
16. + T cells. J Immunol 151:2497-2510
17. 17. Castle BE, Kishimoto K, Stearns C, Brown ML, Kehry MR (1993) Regulation of expression of the ligand for CD40 on T helper lymphocytes. J Immunol 151:1777-1788
18. 18. Henn V, Slupsky JR, Grafe M, Anagnostopoulos I, Forster R, Muller-Berghaus G, Kroczek RA (1998) CD40 ligand on activated platelets triggers an inflammatory reaction of endothelial cells. Nature 391:591-594
19. 19. Gauchat JF, Henchoz S, Mazzei G, Aubry JP, Brunner T, Blasey H, Life P, Talabot D, Flores-Romo L, Thompson J et al (1993) Induction of human IgE synthesis in B cells by mast cells and basophils. Nature 365:340-343
20. 20. Gauchat JF, Henchoz S, Fattah D, Mazzei G, Aubry JP, Jomotte T, Dash L, Page K, Solari R, Aldebert D et al (1995) CD40 ligand is functionally expressed on human eosinophils. Eur J Immunol 25:863-865
21. 21. Bjorck P, Elenstrom-Magnusson C, Rosen A, Severinson E, Paulie S (1993) CD23 and CD21 function as adhesion molecules in homotypic aggregation of human B lymphocytes. Eur J Immunol 23:1771-1775
22. 22. Valle A, Zuber CE, Defrance T, Djossou O, De Rie M, Banchereau J (1989) Activation of human B lymphocytes through CD40 and interleukin 4. Eur J Immunol 19:1463-1467
23. 23. Spriggs MK, Armitage RJ, Strockbine L, Clifford KN, Macduff BM, Sato TA, Maliszewski CR, Fanslow WC (1992) Recombinant human CD40 ligand stimulates B cell proliferation and immunoglobulin E secretion. J Exp Med 176: 1543-1550
24. 24. Rousset F, Garcia E, Banchereau J (1991) Cytokine-induced proliferation and immunoglobulin production of human B lymphocytes triggered through their CD40 antigen. J Exp Med 173:705-710
25. 25. Banchereau J, Rousset F (1991) Growing human B lymphocytes in the CD40 system. Nature 353:678-679
26. 26. Boussiotis VA, Nadler LM, Strominger JL, Goldfeld AE (1994) Tumor necrosis factor alpha is an autocrine growth factor for normal human B cells. Proc Natl Acad Sci USA 91:7007-7011
27. 27. Burdin N, Van Kooten C, Galibert L, Abrams JS, Wijdenes J, Banchereau J, Rousset F (1995) Endogenous IL-6 and IL-10 contribute to the differentiation of CD40-activated human B lymphocytes. J Immunol 154:2533-2544
28. 28. Worm M, Geha RS (1994) CD40 ligation induces lymphotoxin alpha gene expression in human B cells. Int Immunol 6:1883-1890
29. 29. Rathmell JC, Townsend SE, Xu JC, Flavell RA, Goodnow CC (1996) Expansion or elimination of B cells in vivo: dual roles for CD40-and Fas (CD95)-ligands modulated by the B cell antigen receptor. Cell 87:319-329
30. 30. Jumper MD, Splawski JB, Lipsky PE, Meek K (1994) Ligation of CD40 induces sterile transcripts of multiple Ig H chain isotypes in human B cells. J Immunol 152:438-445
31. 31. Jabara HH, Fu SM, Geha RS, Vercelli D (1990) CD40 and IgE: synergism between anti-CD40 monoclonal antibody and interleukin 4 in the induction of IgE synthesis by highly purified human B cells. J Exp Med 172:1861-1864
32. 32. Armitage RJ, Macduff BM, Spriggs MK, Fanslow WC (1993) Human B cell proliferation and Ig secretion induced by recombinant CD40 ligand are modulated by soluble cytokines. J Immunol 150:3671-3680
33. 33. Foy TM, Laman JD, Ledbetter JA, Aruffo A, Claassen E, Noelle RJ (1994) gp39-CD40 interactions are essential for germinal center formation and the development of B cell memory. J Exp Med 180:157-163
34. 34. van Kooten C, Banchereau J (1997) Functions of CD40 on B cells, dendritic cells and other cells. Curr Opin Immunol 9:330-337
35. 35. Caux C, Massacrier C, Vanbervliet B, Dubois B, Van Kooten C, Durand I, Banchereau J (1994) Activation of human dendritic cells through CD40 cross-linking. J Exp Med 180:1263-1272
36. 36. Tian L, Noelle RJ, Lawrence DA (1995) Activated T cells enhance nitric oxide production by murine splenic macrophages through gp39 and LFA-1. Eur J Immunol 25:306-309
37. 37. Karmann K, Hughes CC, Schechner J, Fanslow WC, Pober JS (1995) CD40 on human endothelial cells: inducibility by cytokines and functional regulation of adhesion molecule expression. Proc Natl Acad Sci USA 92:4342-4346
38. 38. Rothe M, Wong SC, Henzel WJ, Goeddel DV (1994) A novel family of putative signal transducers associated with the cytoplasmic domain of the 75 kDa tumor necrosis factor receptor. Cell 78:681-692
39. 39. Cheng G, Cleary AM, Ye ZS, Hong DI, Lederman S, Baltimore D (1995) Involvement of CRAF1, a relative of TRAF, in CD40 signaling. Science 267:1494-1498
40. 40. Takeuchi M, Rothe M, Goeddel DV (1996) Anatomy of TRAF2. Distinct domains for nuclear factor-kappaB activation and association with tumor necrosis factor signaling proteins. J Biol Chem 271:19935-19942
41. 41. Ishida T, Mizushima S, Azuma S, Kobayashi N, Tojo T, Suzuki K, Aizawa S, Watanabe T, Mosialos G, Kieff E, Yamamoto T, Inoue J (1996) Identification of TRAF6, a novel tumor necrosis factor receptor-associated factor protein that mediates signaling from an amino-terminal domain of the CD40 cytoplasmic region. J Biol Chem 271:28745-28748
42. 42. Hu HM, O'Rourke K, Boguski MS and Dixit VM (1994) A novel RING finger protein interacts with the cytoplasmic domain of CD40. J Biol Chem 269:30069-30072
43. 43. Kuhne MR, Robbins M, Hambor JE, Mackey MF, Kosaka Y, Nishimura T, Gigley JP, Noelle RJ, Calderhead DM (1997) Assembly and regulation of the CD40 receptor complex in human B cells. J Exp Med 186:337-342
44. 44. Ishida TK, Tojo T, Aoki T, Kobayashi N, Ohishi T, Watanabe T, Yamamoto T, Inoue J (1996) TRAF5, a novel tumor necrosis factor receptor-associated factor family protein, mediates CD40 signaling. Proc Natl Acad Sci USA 93:9437-9442
45. 45. Kashiwada M, Shirakata Y, Inoue JI, Nakano H, Okazaki K, Okumura K, Yamamoto T, Nagaoka H, Takemori T (1998) Tumor necrosis factor receptor-associated factor 6 (TRAF6) stimulates extracellular signal-regulated kinase (ERK) activity in CD40 signaling along a ras-independent pathway. J Exp Med 187:237-244
46. 46. Rothe M, Sarma V, Dixit VM, Goeddel DV (1995) TRAF2-mediated activation of NF-kappa B by TNF receptor 2 and CD40. Science 269:1424-1427
47. 47. Aruffo A, Farrington M, Hollenbaugh D, Li X, Milatovich A, Nonoyama S, Bajorath J, Grosmaire LS, Stenkamp R, Neubauer M et al (1993) The CD40 ligand, gp39, is defective in activated T cells from patients with X-linked hyper-IgM syndrome. Cell 72:291-300
48. 48. Allen RC, Armitage RJ, Conley ME, Rosenblatt H, Jenkins NA, Copeland NG, Bedell MA, Edelhoff S, Disteche CM, Simoneaux DK et al (1993) CD40 ligand gene defects responsible for X-linked hyper-IgM syndrome [see comments]. Science 259:990-993
49. 49. Korthauer U, Graf D, Mages HW, Briere F, Padayachee M, Malcolm S, Ugazio AG, Notarangelo LD, Levinsky RJ, Kroczek RA (1993) Defective expression of T-cell CD40 ligand causes X-linked immunodeficiency with hyper-IgM [see comments]. Nature 361:539-541
50. 50. DiSanto JP, Bonnefoy JY, Gauchat JF, Fischer A, de Saint Basile G (1993) CD40 ligand mutations in x-linked immunodeficiency with hyper-IgM [see comments]. Nature 361:541-543
51. 51. Fuleihan R, Ramesh N, Loh R, Jabara H, Rosen RS, Chatila T, Fu SM, Stamenkovic I, Geha RS (1993) Defective expression of the CD40 ligand in X chromosome-linked immunoglobulin deficiency with normal or elevated IgM. Proc Natl Acad Sci USA 90:2170-2173
52. 52. Farrington M, Grosmaire LS, Nonoyama S, Fischer SH, Hollenbaugh D, Ledbetter JA, Noelle RJ, Aruffo A, Ochs HD (1994) CD40 ligand expression is defective in a subset of patients with common variable immunodeficiency. Proc Natl Acad Sci USA 91:1099-1103
53. 53. Conley ME, Larche M, Bonagura VR, Lawton ARr, Buckley RH, Fu SM, Coustan-Smith E, Herrod HG, Campana D (1994) Hyper IgM syndrome associated with defective CD40-mediated B cell activation [see comments]. J Clin Invest 94:1404-1409
54. 54. Durandy A, Hivroz C, Mazerolles F, Schiff C, Bernard F, Jouanguy E, Revy P, DiSanto JP, Gauchat JF, Bonnefoy JY, Casanova JL, Fischer A (1997) Abnormal CD40-mediated activation pathway in B lymphocytes from patients with hyper-IgM syndrome and normal CD40 ligand expression. J Immunol 158:2576-2584
55. 55. Durie FH, Fava RA, Foy TM, Aruffo A, Ledbetter JA, Noelle RJ (1993) Prevention of collagen-induced arthritis with an antibody to gp39, the ligand for CD40. Science 261: 1328-1330
56. 56. Mohan C, Shi Y, Laman JD, Datta SK (1995) Interaction between CD40 and its ligand gp39 in the development of murine lupus nephritis. J Immunol 154:1470-1480
57. 57. Jacquot S, Kobata T, Iwata S, Morimoto C, Schlossman SF (1997) CD154/CD40 and CD70/CD27 interactions have different and sequential functions in T cell-dependent B cell responses: enhancement of plasma cell differentiation by CD27 signaling. J Immunol 159:2652-2657
58. 58. Stuber E, Strober W (1996) The T cell-B cell interaction via OX40-OX40L is necessary for the T cell-dependent humoral immune response. J Exp Med 183:979-989
59. 59. Balasa B, Krahl T, Patstone G, Lee J, Tisch R, McDevitt HO, Sarvetnick N (1997) CD40 ligand-CD40 interactions are necessary for the initiation of insulitis and diabetes in nonobese diabetic mice. J Immunol 159:4620-4627
60. 60. Griggs ND, Agersborg SS, Noelle RJ, Ledbetter JA, Linsley PS, Tung KS (1996) The relative contribution of the CD28 and gp39 costimulatory pathways in the clonal expansion and pathogenic acquisition of self-reactive T cells. J Exp Med 183:801-810
61. 61. Noelle RJ (1996) CD40 and its ligand in host defense. Immunity 4:415-419
62. 62. Stuber E, Strober W, Neurath M (1996) Blocking the CD40L-CD40 interaction in vivo specifically prevents the priming of T helper 1 cells through the inhibition of interleukin 12 secretion. J Exp Med 183:693-698
63. 63. Gerritse K, Laman JD, Noelle RJ, Aruffo A, Ledbetter JA, Boersma WJ, Claassen E (1996) CD40-CD40 ligand interactions in experimental allergic encephalomyelitis and multiple sclerosis. Proc Natl Acad Sci USA 93:2499-2504
64. 64. Carayanniotis G, Masters SR, Noelle RJ (1997) Suppression of murine thyroiditis via blockade of the CD40-CD40L interaction. Immunology 90:421-426
65. 65. Campbell KA, Ovendale PJ, Kennedy MK, Fanslow WC, Reed SG, Maliszewski CR (1996) CD40 ligand is required for protective cell-mediated immunity to Leishmania major. Immunity 4:283-289
66. 66. Soong L, Xu JC, Grewal IS, Kima P, Sun J, Longley BJ, Jr, Ruddle NH, McMahon-Pratt D, Flavell RA (1996) Disruption of CD40-CD40 ligand interactions results in an enhanced susceptibility to Leishmania amazonensis infection. Immunity 4:263-273
67. 67. Kamanaka M, Yu P, Yasui T, Yoshida K, Kawabe T, Horii T, Kishimoto T, Kikutani H (1996) Protective role of CD40 in Leishmania major infection at two distinct phases of cellmediated immunity. Immunity 4:275-281
68. 68. Wiley JA, Harmsen AG (1995) CD40 ligand is required for resolution of Pneumocystis carinii pneumonia in mice. J Immunol 155:3525-3529
69. 69. Laman JD, de Smet BJ, Schoneveld A, van Meurs M (1997) CD40-CD40L interactions in atherosclerosis. Immunol Today 18:272-277
70. 70. Mach F, Schonbeck U, Sukhova GK, Atkinson E, Libby P (1998) Reduction in atherosclerosis in mice by inhibition of CD40 signalling. Nature 394:200-203
71. 71. Durie FH, Aruffo A, Ledbetter J, Crassi KM, Green WR, Fast LD, Noelle RJ (1994) Antibody to the ligand of CD40, gp39, blocks the occurrence of the acute and chronic forms of graft-vs-host disease. J Clin Invest 94:1333-1338
72. 72. Parker DC, Greiner DL, Phillips NE, Appel MC, Steele AW, Durie FH, Noelle RJ, Mordes JP, Rossini AA (1995) Survival of mouse pancreatic islet allografts in recipients treated with allogeneic small lymphocytes and antibody to CD40 ligand. Proc Natl Acad Sci USA 92:9560-9564
73. 73. Larsen CP, Alexander DZ, Hollenbaugh D, Elwood ET, Ritchie SC, Aruffo A, Hendrix R, Pearson TC (1996) CD40-gp39 interactions play a critical role during allograft rejection. Suppression of allograft rejection by blockade of the CD40-gp39 pathway. Transplant 61:4-9
74. 74. Kirk AD, Harlan DM, Armstrong NN, Davis TA, Dong Y, Gray GS, Hong X, Thomas D, Fechner JH, Jr, Knechtle SJ (1997) CTLA4-Ig and anti-CD40 ligand prevent renal allograft rejection in primates. Proc Natl Acad Sci USA 94:8789-8794
75. 75. Larsen CP, Elwood ET, Alexander DZ, Ritchie SC, Hendrix R, Tucker-Burden C, Cho HR, Aruffo A, Hollenbaugh D, Linsley PS, Winn KJ, Pearson TC (1996) Long-term acceptance of skin and cardiac allografts after blocking CD40 and CD28 pathways. Nature 381:434-438
76. 76. Larsen CP, Pearson TC (1997) The CD40 pathway in allograft rejection, acceptance, and tolerance. Curr Opin Immunol 9:641-647
77. 77. Mackey MF, Gunn JR, Ting PP, Kikutani H, Dranoff G, Noelle RJ and Barth RJ, Jr (1997) Protective immunity induced by tumor vaccines requires interaction between CD40 and its ligand, CD154. Can Res 57:2569-2574
78. 78. Mackey MF, Barth RJ, Noelle RJ (1998) The role of CD40/CD154 interactions in the priming, differentiation, and effector function of helper and cytotoxic T cells. J Leukocyte Biol 63:418-428